Third Randomized Intervention Treatment of Angina - RITA-3


This was a randomized trial comparing an early invasive approach with a selective invasive approach in patients with unstable angina/non–ST-segment elevation myocardial infarction (NSTEMI).

Contribution to the Literature: The RITA-3 trial showed that invasive therapy was associated with a reduction in early death, MI, or refractory angina at 4 months.